# Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults

> **NCT03651947** · PHASE1 · COMPLETED · sponsor: **Qilu Pharmaceutical Co., Ltd.** · enrollment: 168 (actual)

## Conditions studied

- Healthy People

## Interventions

- **DRUG:** QL1206
- **DRUG:** Xgeva®

## Key facts

- **NCT ID:** NCT03651947
- **Lead sponsor:** Qilu Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-20
- **Primary completion:** 2018-11-17
- **Final completion:** 2019-05-22
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2019-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03651947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03651947, "Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03651947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*